AAAAAA

   
Results: 1-18 |
Results: 18
EFFECTS OF THE ALPHA-PARTICLE EMITTER AT-211 AND LOW-DOSE-RATE GAMMA-RADIATION ON THE HUMAN CELL-LINE COLO-205 AS STUDIED WITH A GROWTH ASSAY
Authors: PALM S BACK T CLAESSON I DELLE U HULTBORN R JACOBSSON L KOPF I LINDEGREN S
Citation: S. Palm et al., EFFECTS OF THE ALPHA-PARTICLE EMITTER AT-211 AND LOW-DOSE-RATE GAMMA-RADIATION ON THE HUMAN CELL-LINE COLO-205 AS STUDIED WITH A GROWTH ASSAY, Anticancer research, 18(3A), 1998, pp. 1671-1676
EFFECTS OF SURAMIN ON POLYAMINE METABOLISM IN B16 MURINE MELANOMA-CELLS
Authors: GRITLILINDE A BJORKMAN U DELLE U FROSTESJO L HULTBORN R HULTEN K JOHANSSSON BR NANNMARK U LINDE A
Citation: A. Gritlilinde et al., EFFECTS OF SURAMIN ON POLYAMINE METABOLISM IN B16 MURINE MELANOMA-CELLS, Anticancer research, 18(2A), 1998, pp. 855-862
OPPOSING EFFECTS OF SURAMIN AND DL-ALPHA-DIFLUOROMETHYLORNITHINE ON POLYAMINE METABOLISM CONTRIBUTE TO A SYNERGISTIC ACTION ON B16 MELANOMACELL-GROWTH IN-VITRO
Authors: GRITLILINDE A BJORKMAN U DELLE U HULTBORN R JOHANSSSON BR NANNMARK U LINDE A
Citation: A. Gritlilinde et al., OPPOSING EFFECTS OF SURAMIN AND DL-ALPHA-DIFLUOROMETHYLORNITHINE ON POLYAMINE METABOLISM CONTRIBUTE TO A SYNERGISTIC ACTION ON B16 MELANOMACELL-GROWTH IN-VITRO, Anticancer research, 18(2A), 1998, pp. 863-870
GROWTH AND CLONOGENIC ASSAYS COMPARED FOR IRRADIATED MCF-7 AND COLO-205 CELL-LINES
Authors: YANG YY OLOFSSON M KOPF I HULTBORN R
Citation: Yy. Yang et al., GROWTH AND CLONOGENIC ASSAYS COMPARED FOR IRRADIATED MCF-7 AND COLO-205 CELL-LINES, Anticancer research, 18(1A), 1998, pp. 53-59
PROGNOSTIC VALUE OF BONE-MARROW BIOPSY IN OPERABLE BREAST-CANCER PATIENTS AT THE TIME OF INITIAL DIAGNOSIS - RESULTS OF A 20-YEAR MEDIAN FOLLOW-UP
Authors: LANDYS K PERSSON S KOVARIK J HULTBORN R HOLMBERG E
Citation: K. Landys et al., PROGNOSTIC VALUE OF BONE-MARROW BIOPSY IN OPERABLE BREAST-CANCER PATIENTS AT THE TIME OF INITIAL DIAGNOSIS - RESULTS OF A 20-YEAR MEDIAN FOLLOW-UP, Breast cancer research and treatment, 49(1), 1998, pp. 27-33
EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS
Authors: CASTIGLIONEGERTSCH M GOLDHIRSCH A GUSTERSON B BETTELHEIM R REED R GUSSET H GEISER K HURNY C BERNHARD J HANGARTNER A MAIBACH R PEDOWSKI R GELBER R PRICE K PETERSON H ZELEN M ISLEY M HINKLE R KAY RG HOLDAWAY IM HARVEY VJ JAGUSCH MF NEAVE L MASON BM EVANS B BENJAMIN CS CARTER JF GILLMAN JC MACK D BENSONCOOPER D MONFARDINI S GALLIGIONI E CRIVELLARI D BUONADONNA A MASSARUT S ROSSI C CANDIANI E CARBONE A VOLPE R TROVO MG RONCADIN M SANTINI GF VILLALTA D CORAN F MORASSUT S MARINI G SIMONCINI E MARPICATI P ZANIBONI A SARTORI U BARNI A CERUTTI L ALGHISI A RAFFAGLIO E GARATTINI MP ALBERTINI A GRIGOLATO F MORASSI L BERGONZINI R LAURIOLA C GUDGEON A DENT DM TILTMAN A HACKING A DOWDLE E STEYNOR P TOOP J SCHNURCH HG MOSNY D BENDER HG BOJAR H VERONESI A FOLADORE S PAMICH G BIANCHI G TORRETTA A RUDENSTAM CM WALLGREN A PERSSON S MATTSSON J CAHLIN E HAFSTROM LO HOLMBERG S HULTBORN R COLLDAHLJADERSTROM G GUSTAVSSON B CARLSSON G IVARSSON L THOREN O RUUSVIK O NICKLASSON LG DAHLIN S KARLSSON G LINDBERG B SUNDBACK A BERGEGARDH S SALANDER H ANDERSSON C HESSMAN Y NELZEN O HEIDEMAN M RAMHULT T SVENSSON JH LIDBERG P BJORK S LINDTNER J ERZEN D CERAR O STABUC B GOLOUH R LAMOVEC J SEBEK S KRAMBERGER M VRHOVEC I CORTESFUNES H MARTINEZTELLO F MENDIOLA C CRUZVIGO F LARRODERA ML SIERRA A MIRANDA P ALONSO S COLLINS J SNYDER R GREGORY P BURAS WI GREEN M GALE T HENDERSON M HART S NEIL S KITCHEN P LOVELL R MCLENNAN R REED R RUSSELL I SCHWARZ M BASSER R ROBERTSON A GILL P CARTER ML MALYCHA P YEOH E WARD G LEONG ASY LOMMAXSMITH J HOOSFALL D DANGELO R BYRNE M VANHAZEL G DEWAR J BUCK M SHEINER HJ INGRAM D STERRETT G HAHNEL R FORBES JF STEWARD J DARBAR SW BISHOP JM SIMMS B ZIOGAS V TATTERSALL MHN COATES A NIESCHE F WEST R RENWICK S DONOVAN J DUVAL P SIMES RJ NG A GLENN D NORTH RA BEITH J OCONNOR RG RICE M STEVENS G FEY M BARTH A DREHER E ISENSCHMID M SCHNEIDER H BUSER K LUDIN J LUTHI JM ALTERMATT HJ LAISSUE JA MARKWALDER R BURGI H SENN HJ THURLIMANN B JUNGI WF MORANT R OEHLSCHLEGEL C HARDMEIER T LUSCHER K RIES G TOPFER M LORENZ U BENZ D SCHILTKNECHT O SPATI B SCHMID L CAVALLI F SESSA C BRONZ L MARTINELLI G MULLER W LUSCIETI P PASSEGA E PEDRINIS E REY P MARTINOLI S SPINELLI A GALFETTI MA LOMBARDI A PEDRAZZINI A LOSA G VARINI M GINIER M HERRMANN R HARDER JF LAFFER U ALMENDRAL AC EPPENBERGER U TORHORST J SIEGENTHALER P PIGUET D BARRELET V BAUMANN RP JOSS R SAUTER C METZGER U ENGELER V HALLER U KOCHLI O LEYVRAZ S PEREY L ANANI P GOMEZ F MIRIMANOFF RO CHAPUIS G DEGRANDI P REYMOND P ALBERTO P SCHAFER P KRAUER F FORNI M AAPRO M EGELI R MEGEVAND R JACOTDESCOMBES E SCHINDLER A NOSEDA G WEBER W LEHMANN W
Citation: M. Castiglionegertsch et al., EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1385-1394
PHARMACOKINETICS OF DOXORUBICIN AND EPIRUBICIN IN MICE DURING CHLORPROMAZINE-INDUCED HYPOTHERMIA
Authors: LUNDGRENERIKSSON L CARLSSON A EKSBORG S RYD W VESANEN R HULTBORN R
Citation: L. Lundgreneriksson et al., PHARMACOKINETICS OF DOXORUBICIN AND EPIRUBICIN IN MICE DURING CHLORPROMAZINE-INDUCED HYPOTHERMIA, Cancer chemotherapy and pharmacology, 40(5), 1997, pp. 419-424
PREVALENCE OF KLINEFELTERS-SYNDROME IN MALE BREAST-CANCER PATIENTS
Authors: HULTBORN R HANSON C KOPF I VERBIENE I WARNHAMMAR E WEIMARCK A
Citation: R. Hultborn et al., PREVALENCE OF KLINEFELTERS-SYNDROME IN MALE BREAST-CANCER PATIENTS, Anticancer research, 17(6D), 1997, pp. 4293-4297
EFFECTS OF OOPHORECTOMY ON INTERSTITIAL FLUID PRESSURE, BLOOD-FLOW AND VASCULARITY IN A RAT MAMMARY-TUMOR
Authors: HULTBORN R TVEIT E ANGERAS M KOPF I WEISS L
Citation: R. Hultborn et al., EFFECTS OF OOPHORECTOMY ON INTERSTITIAL FLUID PRESSURE, BLOOD-FLOW AND VASCULARITY IN A RAT MAMMARY-TUMOR, Anticancer research, 17(3C), 1997, pp. 1877-1880
IMPROVED SURVIVAL WITH PREOPERATIVE RADIOTHERAPY IN RESECTABLE RECTAL-CANCER
Authors: PAHLMAN L GLIMELIUS B CEDERMARK B LUNDELL G RUBIO C RUTQVIST LE WILKING N OST A BRISMAR B EWERTH S FORSGREN L JOHANSSON C MAGNUSSON I SUNDELIN P SVENSSON C TORNBERG B THEVE T FENYO G SVENSSON SO GOLDMAN S MOLIN K BARK S SUNDBLAD M DALEN J LINDHOLMER C ROBERTSSON B OHMAN U NILSSON SE DAHLBERG M GRAF W JANSSONFRYKHOLM G LINDMARK G WESTMAN M LILJEHOLM H BENDTSEN O LJUNGQUIST U NIHLBERG A HEUMAN R LORENTZ T BISGAARDPEDERSEN A BERGSTROM S KROG M TUVESSON T EDMAN P LINDSTROM C SANDHAMMAR B TYDEN G BERGMAN L ENANDER LK UNDERSKOG I SELLSTROM H ARMATYS P MOELL P HELLBERG R STENSTAM B DAFNIS G HOJER H BALDETORP L HATSCHEK T SJODAHL R ARBMAN G NILSSON E STORGRENFORDELL V HUGANDER A LAGERBERG F SIMERT G DELARUE RA ALDMAN A LANNERSTAD O GULLSTRAND P ARWIDI A BOHE M EKELUND G JIBORN H LANDBERG T GRAFFMAN S JANSSON O JEPPSON B SORBRIS R OHLSSON E LENNINGER S HALLDEN K NORRYD C ADAMSEN S HULTBORN R NILSSON S MAGNUSSON O SODERBERG HE LINDBERG B TVEIT E JANSSON R SVENSSON JH GUSTAFSSON A ALMSKOG B SALANDER H HOLMLUND D FILIPSSON S LAINO R ATHLIN L BENGTSSON NO GROMAN G LUNDEGARD G DEDORSON S HENRIKSSON G NORDAHL A RYD G EDLUND G SVENSSON JO RUTEGARD J FAGERBERG M EDIN K
Citation: L. Pahlman et al., IMPROVED SURVIVAL WITH PREOPERATIVE RADIOTHERAPY IN RESECTABLE RECTAL-CANCER, The New England journal of medicine, 336(14), 1997, pp. 980-987
LOCAL RECURRENCE RATE IN A RANDOMIZED MULTICENTER TRIAL OF PREOPERATIVE RADIOTHERAPY COMPARED WITH OPERATION ALONE IN RESECTABLE RECTAL-CARCINOMA
Authors: PAHLMAN L GLIMELIUS B CEDERMARK B LUNDELL G RIEGER A RUTQUIST LE THEVE T WILKING N BENGTSSON NO BLOMGREN H RUBIO C OST A BRISMAR B WIKSTROM B EWERTH S DAHLGREN S FORSGREN L FRIBERG S JOHANSSON C MAGNUSSON I SUNDELIN P SVENSSON C TORNBERG B FENYO G LJUNGDAHL I SVENSSON SO MOLIN K GOLDMAN S LASARETT V BARK S ROBERTSSON B DALEN J RAF L OHMAN U NILSSON SE WESTMAN M LILJEHOLM H BENDZEN O LJUNQUIST U NIHLBERG A HEUMAN R LORENTZ T BISGAARDPEDERSEN A BERGSTROM S KROG M TUVESSON T EDMAN P LINDSTROM C SANDHAMMAR B TYDEN G BERGMAN L ENANDER LK UNDERSKOG I SELLSTROM H ARMATYS P MOELL P HELLBERG R STENSTAM B DAFNIS G HOJER H BALDETORP L HATSCHEK T SJODAHL R ARBMAN G NILSSON E STORGRENFORDELL V HUGANDER A LAGERBERG F SIMERT G DELARUE RA ALDMAN A LANNERSTAD O GULLSTRAND P ARWIDI A BOHE M EKELUND G JIBORN H LANDBERG T GRAFFMAN S JANSSON O JEPPSON B SORBRIS R OHLSSON E LENNINGER S HALLDEN K NORRYD C ADAMSEN S HULTBORN R NILSSON S MAGNUSSON O SODERBERG HE LINDBERG B TVEIT E JANSSON R SVENSSON JH GUSTAFSSON A ALMSKOG BA SALANDER H HOLMLUND D FILIPSSON S LAINO R ATHLIN L BROMAN G LUNDEGARD G DAHLBERG M DEDORSON S HENRIKSSON G NORDAHL A RYD G EDLUND G SVENSSON JO RUTEGARD J FAGERBERG M EDIN K
Citation: L. Pahlman et al., LOCAL RECURRENCE RATE IN A RANDOMIZED MULTICENTER TRIAL OF PREOPERATIVE RADIOTHERAPY COMPARED WITH OPERATION ALONE IN RESECTABLE RECTAL-CARCINOMA, The European journal of surgery, 162(5), 1996, pp. 397-402
EFFICACY OF PAMIDRONATE IN BREAST-CANCER WITH BONE METASTASES - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY
Authors: HULTBORN R GUNDERSEN S RYDEN S HOLMBERG E CARSTENSEN J WALLGREN UB KILANY S
Citation: R. Hultborn et al., EFFICACY OF PAMIDRONATE IN BREAST-CANCER WITH BONE METASTASES - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY, Acta oncologica, 35(5), 1996, pp. 73-74
2ND-LINE ENDOCRINE TREATMENT OF ADVANCED BREAST-CANCER - A RANDOMIZEDCROSS-OVER STUDY OF MEDROXY-PROGESTERONE ACETATE AND AMINOGLUTETHIMIDE
Authors: HULTBORN R JOHANSSONTERJE I BERGH J GLAS U HALLSTEN L HATSCHEK T HOLMBERG E IDESTROM K NORBERG B RANSTAM J SODERBERG M WALLGREN UB
Citation: R. Hultborn et al., 2ND-LINE ENDOCRINE TREATMENT OF ADVANCED BREAST-CANCER - A RANDOMIZEDCROSS-OVER STUDY OF MEDROXY-PROGESTERONE ACETATE AND AMINOGLUTETHIMIDE, Acta oncologica, 35(5), 1996, pp. 75-75
VASCULAR CROSS-SECTIONAL AREA IN RAT MAMMARY-TUMORS - INFLUENCE OF NORADRENALINE
Authors: KOPF I HULTBORN R WEISS L CARLSSON A
Citation: I. Kopf et al., VASCULAR CROSS-SECTIONAL AREA IN RAT MAMMARY-TUMORS - INFLUENCE OF NORADRENALINE, Anticancer research, 16(3A), 1996, pp. 1161-1164
CHLORPROMAZINE-INDUCED HYPOTHERMIA - EFFECT ON TUMOR PROGRESSION AND SURVIVAL IN MICE
Authors: LUNDGRENERIKSSON L CARLSSON A OTOSSONLONN S RYD W HULTBORN R
Citation: L. Lundgreneriksson et al., CHLORPROMAZINE-INDUCED HYPOTHERMIA - EFFECT ON TUMOR PROGRESSION AND SURVIVAL IN MICE, Anticancer research, 16(1), 1996, pp. 333-335
EFFICACY OF PAMIDRONATE ON SKELETAL COMPLICATIONS FROM BREAST-CANCER METASTASES - A PROSPECTIVE RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
Authors: HULTBORN R RYDEN S GUNDERSEN S HOLMBERG E WALLGREN UB
Citation: R. Hultborn et al., EFFICACY OF PAMIDRONATE ON SKELETAL COMPLICATIONS FROM BREAST-CANCER METASTASES - A PROSPECTIVE RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL, European journal of cancer, 31A, 1995, pp. 350-350
PROGNOSTIC VALUE OF BONE-MARROW BIOPSY IN OPERABLE BREAST-CANCER PATIENTS AT THE TIME OF INITIAL DIAGNOSIS - RESULTS OF A 19-YEAR MEDIAN FOLLOW-UP
Authors: LANDYS K PERSSON S KOVARIK J HULTBORN R HOLMBERG E
Citation: K. Landys et al., PROGNOSTIC VALUE OF BONE-MARROW BIOPSY IN OPERABLE BREAST-CANCER PATIENTS AT THE TIME OF INITIAL DIAGNOSIS - RESULTS OF A 19-YEAR MEDIAN FOLLOW-UP, European journal of cancer, 31A, 1995, pp. 647-647
DNA CONTENT AND S-PHASE FRACTION IN MALE BREAST CARCINOMAS
Authors: HATSCHEK T WINGREN S CARSTENSEN J HULTBORN R
Citation: T. Hatschek et al., DNA CONTENT AND S-PHASE FRACTION IN MALE BREAST CARCINOMAS, Acta oncologica, 33(6), 1994, pp. 609-613
Risultati: 1-18 |